The Lead Episode 137: A Discussion of Impact of Hospital VT Ablation Volume on Post-Procedural Complications episode artwork

EPISODE · Feb 19, 2026 · 23 MIN

The Lead Episode 137: A Discussion of Impact of Hospital VT Ablation Volume on Post-Procedural Complications

from The Lead Podcast presented by Heart Rhythm Society · host Heart Rhythm Society

Join Digital Education Committee Vice-Chair and podcast host Tina Baykaner, MD, MPH, along with this week's guest contributors, Jackson J. Liang, DO and Edward P. Gerstenfeld, MD, MS, FHRS for this week's episode. This study evaluates the relationship between hospital ventricular tachycardia (VT) ablation volume and post-procedural complications, examining whether institutional procedural experience influences patient outcomes. The authors analyze complication rates across centers with varying VT ablation volumes to assess potential volume–outcome associations. Findings from this work provide important insights into procedural risk, quality metrics, and the potential impact of case volume on VT ablation safety.    Learning Objectives Describe the relationship between hospital VT ablation procedural volume and post-procedural complication rates. Identify patient, procedural, and institutional factors that may contribute to complications following ventricular tachycardia ablation. Discuss how volume–outcome findings can inform quality improvement initiatives, referral patterns, and procedural planning for VT ablation programs.    Article Authors Agam Bansal, Anirudh Nandan, Jakub Sroubek, Justin Lee, Koji Higuchi, Ayman Hussein, Shady Nakhla, Mina Chung, Niraj Varma, Walid Saliba, Mandeep Bhargava, Tyler Taigen, Mohamed Kanj, Oussama Wazni, and Pasquale Santangeli Podcast Contributors Tina Baykaner, MD, MPH Jackson J. Liang, DO Edward P. Gerstenfeld, MD, MS, FHRS   All relevant financial relationships have been mitigated. Host and Contributor Disclosure(s): T. Baykaner•Honoraria/Speaking/Consulting: Volta Medical, Medtronic, Pacemate, Johnson and Johnson, Abbot Medical, Boston Scientific •Research: NIH   E. Gerstenfeld •Speaking/Teaching/Consulting: Medtronic, Adiago Medical, Biosense Webster, Inc., Abbott, Boston Scientific, Abbott Medical, Varian Medical Systems •Research: Boston Scientific, Abbott Medical •Board Membership: American College of Cardiology Foundation   J. Liang •Speaking/Teaching/Consulting: Biotronik, Abbott, Bionsense Webster, Inc.   Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner): S. Sailor: No relevant financial relationships with ineligible companies to disclose.

Episode metadata supplied by the publisher feed · Published Feb 19, 2026

Embed this episode

Ready to play

The Lead Episode 137: A Discussion of Impact of Hospital VT Ablation Volume on Post-Procedural Complications

0:00 23:02

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Lead Podcast presented by Heart Rhythm Society?

This episode is 23 minutes long.

When was this The Lead Podcast presented by Heart Rhythm Society episode published?

This episode was published on February 19, 2026.

Can I download this The Lead Podcast presented by Heart Rhythm Society episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!